Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant

Meagan Jacoby, MD PhD, Eric J. Duncavage, MD, Gue Su Chang, PhD, Christopher A Miller, PhD, Jin Shao, Kevin Elliot, Joshua Robinson, Robert S Fulton, Catrina Fronick, Michelle O'Laughlin, Daniel C. Link, MD, John F DiPersio, MD PhD, Peter Westervelt, MDPhD, Timothy James J Ley, MD, Timothy Aaron Graubert, MD, Matthew J. Walter, MD

Blood (2017) 130 (Supplement 1): 4232.

https://doi.org/10.1182/blood.V130.Suppl_1.4232.4232

Published: 2017

Journal Articles

Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML

Geoffrey L. Uy, MD, Michael P Rettig, PhD, Theresa Fletcher, Peter A Riedell, MD, Keith E. Stockerl-Goldstein, MD, Armin Ghobadi, MD, Meagan Jacoby, MD PhD, Amanda F. Cashen, MD, Rizwan Romee, MD, Iskra Pusic, MD, Camille N. Abboud, MD, Mark A. Schroeder, MD, Ravi Vij, MDMBA, Peter Westervelt, MDPhD, John F DiPersio, MD PhD

Blood (2017) 130 (Supplement 1): 816.

https://doi.org/10.1182/blood.V130.Suppl_1.816.816

Published: 2017

Journal Articles

A Pilot Study of CX-01 with Azacitidine for Treatment of Hypomethylating Agent-Refractory AML and MDS

Eric Huselton, MD, Amanda F. Cashen, MD, John F DiPersio, MD PhD, Meagan Jacoby, MD PhD, Iskra Pusic, MD, Rizwan Romee, MD, Geoffrey L. Uy, MD, Peter Westervelt, MDPhD

Blood (2017) 130 (Supplement 1): 5067.

https://doi.org/10.1182/blood.V130.Suppl_1.5067.5067

Published: 2017

Journal Articles

Ultra-Deep Sequencing As a Predictive Tool for MDS Progression after Allogeneic Hematopoietic Cell Transplant

Eric J. Duncavage, MD, Meagan Jacoby, MD PhD, Gue Su Chang, PhD, Christopher A Miller, PhD, Natasha Edwin, MD, Geoffrey L. Uy, MD, Joshua Robinson, Haley J Abel, PhD, Jin Shao, Kevin Elliot, Robert Fulton, Catrina Fronick, Michelle O'Laughlin, John F DiPersio, MD PhD, Timothy J Ley, MD, Kathryn Trinkaus, PhD, Timothy Aaron Graubert, MD, Matthew J. Walter, MD

Blood (2017) 130 (Supplement 1): 1669.

https://doi.org/10.1182/blood.V130.Suppl_1.1669.1669

Published: 2017

Journal Articles

A Study of High Dose Lenalidomide Induction and Low Dose Lenalidomide Maintenance for Patients with Hypomethylating Agent Refractory MDS

Mathew A. Cherian, MD, Raoul Tibes, MD PhD, Theresa Fletcher, MS, Mark A. Fiala, BS, CCRP, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Keith E. Stockerl-Goldstein, MD, Meagan Jacoby, MD PhD, Amanda F. Cashen, MD, John F. DiPersio, MD PhD, Ravi Vij, MD

Blood (2014) 124 (21): 1931.

https://doi.org/10.1182/blood.V124.21.1931.1931

Published: 2014

Journal Articles

Donor-to-Recipient Weight Ratio Is Independently Associated with CD34 + Yield in Healthy Donors Undergoing Peripheral Blood Stem Cell Collection for Allogeneic Transplantation

Mark A Fiala, BS, CCRP, Soo Park, MD, Camille N. Abboud, MD, Amanda F. Cashen, MD, Meagan Jacoby, MD PhD, Iskra Pusic, MD, Rizwan Romee, MD, Mark A. Schroeder, MD, Geoffrey L. Uy, MD, Ravi Vij, MBBS, MD, Peter Westervelt, MD PhD, Tanya M Wildes, MD MSCI, John F. DiPersio, MD PhD, Keith E. Stockerl-Goldstein, MD

Blood (2014) 124 (21): 2456.

https://doi.org/10.1182/blood.V124.21.2456.2456

Published: 2014

Journal Articles

Remobilization with G-CSF Is Less Effective Than the Initial Mobilization in Healthy Donors Undergoing Peripheral Blood Stem Cell Collection for Allogeneic Transplantation

Blood (2014) 124 (21): 850.

https://doi.org/10.1182/blood.V124.21.850.850

Published: 2014

Journal Articles

A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia

Lukas D. Wartman, MD, Mark A. Fiala, BS, CCRP, Emily Hawkins, BS, Theresa Fletcher, MS, Melissa Allen, Amanda F. Cashen, MD, John F. DiPersio, MD PhD, Meagan Jacoby, MD PhD, Keith E. Stockerl-Goldstein, MD, Iskra Pusic, MD, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MBBS, MD

Blood (2014) 124 (21): 5292.

https://doi.org/10.1182/blood.V124.21.5292.5292

Published: 2014

NARROW

Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant

Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML

A Pilot Study of CX-01 with Azacitidine for Treatment of Hypomethylating Agent-Refractory AML and MDS

Ultra-Deep Sequencing As a Predictive Tool for MDS Progression after Allogeneic Hematopoietic Cell Transplant

A Study of High Dose Lenalidomide Induction and Low Dose Lenalidomide Maintenance for Patients with Hypomethylating Agent Refractory MDS

Donor-to-Recipient Weight Ratio Is Independently Associated with CD34 + Yield in Healthy Donors Undergoing Peripheral Blood Stem Cell Collection for Allogeneic Transplantation

Remobilization with G-CSF Is Less Effective Than the Initial Mobilization in Healthy Donors Undergoing Peripheral Blood Stem Cell Collection for Allogeneic Transplantation

A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only